Report : A-Z CDF items in Formulary 21/10/2025 07:37:43

[Back]

Section Status Homecare Name 10.01.03 Formulary Abatacept Orencia® 10.01.03 Formulary Adalimumab  13.05.03 Formulary Adalimumab  10.01.03 Formulary Apremilast Otezla® 13.05.03 Formulary Apremilast Otezla® 10.01.03 Formulary Baricitinib  10.01.03 Formulary Bimekizumab Bimzelx® 13.05.03 Formulary Bimekizumab Bimzelx ® 10.01.03 Formulary Certolizumab Pegol Cimzia® 13.05.03 Formulary Dupilumab Dupixent® 02.11 Formulary Emicizumab Hemlibra® 10.01.03 Formulary Etanercept  13.05.03 Formulary Etanercept  10.01.03 Formulary Filgotinib  Jyseleca® 10.01.03 Formulary Golimumab Simponi® 10.01.03 Formulary Guselkumab Tremfya® 13.05.03 Formulary Guselkumab Tremfya® 10.01.03 Formulary Infliximab  10.01.03 Formulary Ixekizumab Taltz® 13.05.03 Formulary Methotrexate  10.01.03 Formulary Risankizumab Skyrizi® 10.01.03 Formulary Sarilumab Kevzara® 10.01.03 Formulary Secukinumab Cosentyx® 13.05.03 Formulary Secukinumab Cosentyx® 10.01.03 Formulary Tocilizumab Biosimilars avaliable 10.01.03 Formulary Tofacitinib Xeljanz® 10.01.03 Formulary Upadacitinib  Rinvoq ® 13.05.03 Formulary Upadacitinib  Rinvoq ® 10.01.03 Formulary Ustekinumab  13.05.03 Formulary Ustekinumab

Lancashire and South Cumbria